- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nippon Chemiphar Co Ltd (4539)
Nippon Chemiphar Co Ltd stock price live, this page displays TYO 4539 stock exchange data. View the 4539 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nippon Chemiphar Co Ltd real time stock price chart below.
What Is the Nippon Chemiphar Co Ltd Stock Price Today?
The Nippon Chemiphar Co Ltd stock price today is 1,457.0.
What Is the Stock Symbol for Nippon Chemiphar Co Ltd?
The stock symbol for Nippon Chemiphar Co Ltd is "4539."
What Stock Exchange Does Nippon Chemiphar Co Ltd Trade On?
Nippon Chemiphar Co Ltd is listed and trades on the Tokyo stock exchange.
Is Nippon Chemiphar Co Ltd a Good Stock to Buy?
Determining whether Nippon Chemiphar Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4539 quote. (ISIN: JP3701600003)
What Is the Nippon Chemiphar Co Ltd Stock Price Today?
The Nippon Chemiphar Co Ltd stock price today is 1,457.0.
What Is the Stock Symbol for Nippon Chemiphar Co Ltd?
The stock symbol for Nippon Chemiphar Co Ltd is "4539."
What Stock Exchange Does Nippon Chemiphar Co Ltd Trade On?
Nippon Chemiphar Co Ltd is listed and trades on the Tokyo stock exchange.
Is Nippon Chemiphar Co Ltd a Good Stock to Buy?
Determining whether Nippon Chemiphar Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4539 quote. (ISIN: JP3701600003)
Tokyo
Currency in JPY
1,457.0
-20.0(-1.35%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,457.0
1,482.0
52 wk Range
1,410.0
1,675.0
4539 Scorecard
Full Analysis
Operates with a significant debt burden
4539 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,457.01,482.0
52 wk Range
1,410.01,675.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4539 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
No news in this category
Looks like there are no results in this news category
Nippon Chemiphar Co Ltd Company Profile
Nippon Chemiphar Co., Ltd., together with its subsidiaries, engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally. the company offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels, as well as 57 individual allergen reagents; and DP3000, a device for allergen-specific IgE measurements. It also develops NC-2400, a PPAR-delta agonist currently under phase 1 development; NC-2500, a XOR inhibitor for the treatment of hyperuricemia/gout currently under phase 1 development; and NC-2600, a P2X4 receptor antagonist for the treatment of neuropathic pain currently under phase 1 development. In addition, the company develops NC-2700, a URAT1 inhibitor for hyperuricemia, guot currently under preclinical development; NC-2800, a delta opioid receptor agonist for the treatment of depression/anxiety currently under Phase 1 development; DFP-17729, a cancer microenvironment improving agent far pancreatic cancer currently under phase 2 development; and DE-P-14323, an anti-cancer agent for non-small cell lung cancer currently under phase 2 development. Further, it is involved in the development of Soleton, an analgesic and anti-inflammatory drug; and Calvan, a blocker for huntington's disease currently under phase 2 development. Additionally, the company provides quasi-drugs, nutrients, health foods, cosmetics, and various types of creams. The company was formerly known as Hitachi Chemical Co., Ltd. and changed its name to Nippon Chemiphar Co., Ltd. in 1970. Nippon Chemiphar Co., Ltd. was incorporated in 1950 and is headquartered in Tokyo, Japan.
Compare 4539 to Peers and Sector
Metrics to compare | 4539 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4539PeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.1x | 10.6x | −0.5x | |
PEG Ratio | 6.32 | 0.14 | 0.00 | |
Price/Book | 0.3x | 1.0x | 2.6x | |
Price / LTM Sales | 0.2x | 1.4x | 2.9x | |
Upside (Analyst Target) | - | 27.3% | 49.4% | |
Fair Value Upside | Unlock | 31.4% | 8.2% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
71.90 / --
Revenue / Forecast
8.26B / --
FAQ
What Is the Nippon Chemiphar (4539) Stock Price Today?
The Nippon Chemiphar stock price today is 1,457.00
What Stock Exchange Does Nippon Chemiphar Trade On?
Nippon Chemiphar is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Nippon Chemiphar?
The stock symbol for Nippon Chemiphar is "4539."
Does Nippon Chemiphar Pay Dividends? What’s The Current Dividend Yield?
The Nippon Chemiphar dividend yield is 3.43%.
What Is the Nippon Chemiphar Market Cap?
As of today, Nippon Chemiphar market cap is 5.26B.
What Is Nippon Chemiphar's Earnings Per Share (TTM)?
The Nippon Chemiphar EPS (TTM) is -69.01.
When Is the Next Nippon Chemiphar Earnings Date?
Nippon Chemiphar will release its next earnings report on 29 July 2025.
From a Technical Analysis Perspective, Is 4539 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.